Follo MY - Search Results

1

Microbiota-Gut-Brain Axis in Neurological Disorders: From Leaky Barriers Microanatomical Changes to Biochemical Processes.

Neri I, Boschetti E, Follo MY, De Giorgio R, Cocco LI, Manzoli L, Ratti S. Neri I, et al. Among authors: follo my. Mini Rev Med Chem. 2023;23(3):307-319. doi: 10.2174/1389557522666220622111501. Mini Rev Med Chem. 2023. PMID: 35733303 Review.

2

Nuclear inositol lipid metabolism: more than just second messenger generation?

Martelli AM, Follo MY, Evangelisti C, Falà F, Fiume R, Billi AM, Cocco L. Martelli AM, et al. Among authors: follo my. J Cell Biochem. 2005 Oct 1;96(2):285-92. doi: 10.1002/jcb.20527. J Cell Biochem. 2005. PMID: 16088939 Review.

3

Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation.

Faenza I, Billi AM, Follo MY, Fiume R, Martelli AM, Cocco L, Manzoli L. Faenza I, et al. Among authors: follo my. Anticancer Res. 2005 May-Jun;25(3B):2039-41. Anticancer Res. 2005. PMID: 16158942 Free article. Review.

4

Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome.

Follo MY, Bosi C, Finelli C, Fiume R, Faenza I, Ramazzotti G, Gaboardi GC, Manzoli L, Cocco L. Follo MY, et al. Int J Mol Med. 2006 Aug;18(2):267-71. Int J Mol Med. 2006. PMID: 16820933

5

Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter.

Faenza I, Ramazzotti G, Bavelloni A, Fiume R, Gaboardi GC, Follo MY, Gilmour RS, Martelli AM, Ravid K, Cocco L. Faenza I, et al. Among authors: follo my. Endocrinology. 2007 Mar;148(3):1108-17. doi: 10.1210/en.2006-1003. Epub 2006 Nov 22. Endocrinology. 2007. PMID: 17122077

6

Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cells.

Cocco L, Follo MY, Faenza I, Bavelloni A, Billi AM, Martelli AM, Manzoli L. Cocco L, et al. Among authors: follo my. Adv Enzyme Regul. 2007;47:2-9. doi: 10.1016/j.advenzreg.2006.12.003. Epub 2007 Mar 1. Adv Enzyme Regul. 2007. PMID: 17335878 Review. No abstract available.

7

The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.

Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, Papa V, Libra M, Martinelli G, Cocco L, Martelli AM. Follo MY, et al. Cancer Res. 2007 May 1;67(9):4287-94. doi: 10.1158/0008-5472.CAN-06-4409. Cancer Res. 2007. PMID: 17483341

8

Nuclear phospholipase C beta1 and cellular differentiation.

Faenza I, Bregoli L, Ramazzotti G, Gaboardi G, Follo MY, Mongiorgi S, Billi AM, Manzoli L, Martelli AM, Cocco L. Faenza I, et al. Among authors: follo my. Front Biosci. 2008 Jan 1;13:2452-63. doi: 10.2741/2858. Front Biosci. 2008. PMID: 17981726 Review.

9

Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes.

Cocco L, Faenza I, Follo MY, Ramazzotti G, Gaboardi GC, Billi AM, Martelli AM, Manzoli L. Cocco L, et al. Among authors: follo my. Adv Enzyme Regul. 2008;48:2-9. doi: 10.1016/j.advenzreg.2007.11.013. Epub 2008 Mar 17. Adv Enzyme Regul. 2008. PMID: 18280812 Review. No abstract available.

10

Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.

Follo MY, Finelli C, Clissa C, Mongiorgi S, Bosi C, Martinelli G, Baccarani M, Manzoli L, Martelli AM, Cocco L. Follo MY, et al. J Clin Oncol. 2009 Feb 10;27(5):782-90. doi: 10.1200/JCO.2008.19.3748. Epub 2008 Dec 29. J Clin Oncol. 2009. PMID: 19114693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters